First American Financial Corp - Common Stock (FAF)

CUSIP: 31847R102

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class
Equity / Common Stock
Total 13F shares
1,846,702
Total 13F value
$126,665,857
Holder snapshot 6 signals
Share change
+274,291
SEC-reported price per share
$68.59
Number of holders
16
Value change
+$18,813,627
Number of buys
9
Number of sells
1
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
102,497,421

Security key

31847R102

Report period

Q2 2026

Institutions

16

Top holders

10

FAF full security history Ownership snapshot Full 13F holder table Previous quarter: Q1 2026 First American Financial Corp SEC filings First American Financial Corp company facts First American Financial Corp 13D/G history

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of FAF - First American Financial Corp - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
22 Jun 2026
13F 13D/G 3/4/5 Lead comparable stake: 9% 13D/G row: FMR LLC Showing 1-6 of 15 holder rows.

Quick read

FMR LLC leads the comparable SEC ownership view at 9%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens FMR LLC's linked filing trail.
Comparable ownership Top 5
FMR LLC 9%
Boston Partners 5.3%
VANGUARD PORTFOLIO MANAGEMENT LLC 5.1%
VANGUARD CAPITAL MANAGEMENT LLC 5%
Parker S. Kennedy 2.4%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
FMR LLC
13F 13D/G
Company
13F 13D/G
9%
from 13D/G
$552,297,295
9,160,679 shares
 — 31 Mar 2026
Boston Partners
13F 13D/G
Company
13F 13D/G
5.3%
from 13D/G
$346,287,979
5,749,224 shares
 — 31 Mar 2026
VANGUARD PORTFOLIO MANAGEMENT LLC
13D/G 13F
Vanguard Portfolio Management · Company
13D/G 13F
5.1%
$315,744,861
5,237,093 shares
 $0 31 Mar 2026
VANGUARD CAPITAL MANAGEMENT LLC
13D/G 13F
Vanguard Capital Management · Company
13D/G 13F
5%
$311,450,819
5,165,870 shares
 $0 31 Mar 2026
Parker S. Kennedy
3/4/5
Director
3/4/5
2.4%
$156,615,270
2,419,516 shares
 +$4,050,101 19 Feb 2026
Dennis J. Gilmore
3/4/5
Director
3/4/5
0.47%
$28,901,458
479,374 shares
 — 22 Jun 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
1,846,702
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
434
Q2 2026 holders
16
Holder diff
-418
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .